相关实验视频

Updated: Jan 17, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

储存温度和抗凝剂的选择决定了血液风湿学参数的短期稳定性

Lennart Kuck¹, Francesco A Frappa², Antony P McNamee¹

¹Biorheology Research Laboratory, Griffith University, Gold Coast, QLD, Australia.

Clinical hemorheology and microcirculation

|September 16, 2025

概括

乙烯二胺乙酸 (EDTA) 是在短期储存期间保留红细胞聚合和变形性的首选抗凝剂. 储存EDTA抗凝血血液在4°C以确保同一天测试的稳定性.

科学领域:

血液学血液学血液学
生物物理学的生物物理.
临床病理学临床病理学

背景情况:

血液的风湿性质受到红细胞 (RBC) 机制和聚合的影响,提供了重要的临床见解.
测量这些属性在phlebotomy网站往往是具有挑战性的,因为需要专门的设备.
短期存储对血液风湿学的影响对于准确的临床检测至关重要.

研究的目的:

评估短期储存条件对红细胞聚合和变形能力的影响.
为了比较肝素与EDTA作为抗凝固剂的有效性,以保持这些特性.
为了确定最佳的储存温度和持续时间,以保持血液样本的完整性.

主要方法:

从健康的志愿者收集血液样本,使用肝素或EDTA.
样品在环境 (22°C) 或冷 (4°C) 温度下保存长达48小时.
通过光传输和激光反射来评估红细胞聚合;使用激光衍射计测量了可变性.

主要成果:

与肝素相比,EDTA显著降低了最初的红细胞聚合.
在环境温度下,EDTA可保持红细胞聚合长达4小时,而肝素在1小时内显示出变化.
储存8小时后,无论抗凝剂如何,红细胞变形性都受到影响.
在4°C的冷藏条件下,最大限度地延长了样品的稳定性,特别是在EDTA抗凝血血液中.

结论:

EDTA是选择的抗凝剂,可以保护血液的物理性质,这与风湿学有关.
短期储存会对血液的物理性质产生重大影响,因此需要谨慎处理和储存方案.
对于当天的测试,储存在4°C的EDTA抗凝血血液保持完整性,不会对关键的风湿学参数产生负面影响.

关键词:

储存血液是为了储存血液.这是一种抗凝血药物.血液类风湿学血液类风湿学红细胞聚合红细胞聚合红细胞的可变性红细胞可变性

更多相关视频

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

相关概念视频

Sample Handling

Sample Handling

Transportation of samples from the collection point to the laboratory, as well as storage and preservation techniques, are crucial for maintaining sample integrity and ensuring accurate and reliable test results.
Samples should be transported carefully from collection points to the laboratory. They should be properly sealed and clearly labeled to prevent cross-contamination. To preserve the sample integrity, optimal temperature conditions during transport are essential. This could involve using...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Drug Product Stability

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...